FDA Probes Liver Damage with Weight Loss Pill Alli

By: Associated Press Email
By: Associated Press Email

WASHINGTON (AP) - The Food and Drug Administration is investigating reports of liver damage in patients taking alli, the only nonprescription weight loss drug approved by the agency.

Regulators say they have received more than 30 reports of liver damage in patients taking alli and Xenical, the prescription version of the drug. Twenty-seven patients had to be hospitalized, and six suffered liver failure.

Alli and Xenical are both marketed by British drugmaker GlaxoSmithKline, though Xenical is manufactured by Swiss firm Roche.

The FDA says it has not established a definitive relationship between the weight loss drugs and liver injury.

The agency says patients should continue using the drugs as directed.


Comments are posted from viewers like you and do not always reflect the views of this station.
powered by Disqus
KOLO-TV 4850 Ampere Drive Reno, NV 89502
Copyright © 2002-2014 - Designed by Gray Digital Media - Powered by Clickability 54587102 - kolotv.com/a?a=54587102
Gray Television, Inc.